MRC Technology’s Director of Drug Discovery, Justin Bryans, is quoted in a Nature Biotechnology article about the Global Drug Development Alliance. You can find the article on the Nature Biotechnology website.
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.